Lee, Ji-Yong <br/><br/>
Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  11 2016 
 - 6673-6678 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.00984-16  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acinetobacter baumannii--drug effects<br/>Adult<br/>Aged<br/>Anti-Bacterial Agents--therapeutic use<br/>Bacteremia--complications<br/>Case-Control Studies<br/>Cross Infection--complications<br/>Female<br/>Gram-Negative Bacterial Infections--complications<br/>Hematologic Neoplasms--complications<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Intensive Care Units<br/>Length of Stay--statistics & numerical data<br/>Levofloxacin--therapeutic use<br/>Male<br/>Middle Aged<br/>Neutropenia--complications<br/>Pseudomonas aeruginosa--drug effects<br/>Respiratory Tract Infections--complications<br/>Risk Factors<br/>Stenotrophomonas maltophilia--drug effects<br/>Survival Analysis<br/>Tertiary Care Centers<br/>Trimethoprim, Sulfamethoxazole Drug Combination--therapeutic use